Literature DB >> 11602620

Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity.

A J Slavin1, J M Soos, O Stuve, J C Patarroyo, H L Weiner, A Fontana, E K Bikoff, S S Zamvil.   

Abstract

The role of processing in antigen (Ag) presentation and T cell activation in experimental allergic encephalomyelitis (EAE) was evaluated in wild-type mice, mice that selectively express either Ii p31 or p41, and mice completely deficient in Ii or H-2M. We demonstrate that processing of myelin oligodendrocyte glycoprotein (MOG) is required for presentation of the dominant encephalitogenic MOG epitope, p35-55. Ii p31- and p41-expressing mice developed EAE with similar incidence to wild-type mice, although p41 mice had a more severe course. Ag-presenting cells (APCs) from Ii- or H-2M-deficient mice could present p35-55, but not MOG, demonstrating that these APCs could not process native MOG. Ii- and H-2M-deficient mice were not susceptible to EAE by immunization with p35-55 or MOG or by adoptive transfer of encephalitogenic T cells. However, CD4+ T cells from p35-55-immunized H-2M-deficient mice proliferated, secreted IFN-gamma, and transferred EAE to wild-type, but not H-2M-deficient, mice. Thus, EAE resistance in H-2M-deficient mice is not due to an inability of APCs to present p35-55, or an intrinsic defect in the encephalitogenic T cell repertoire, but reflects a defect in APC function. Our results indicate that processing is required for initial Ag presentation and CNS T cell activation and suggest that autopathogenic peptides of CNS autoantigen may not be readily available for presentation without processing.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602620      PMCID: PMC209531          DOI: 10.1172/JCI13360

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

Review 1.  Proteolysis in MHC class II antigen presentation: who's in charge?

Authors:  J A Villadangos; H L Ploegh
Journal:  Immunity       Date:  2000-03       Impact factor: 31.745

2.  T-lymphocyte entry into the central nervous system.

Authors:  W F Hickey; B L Hsu; H Kimura
Journal:  J Neurosci Res       Date:  1991-02       Impact factor: 4.164

Review 3.  T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex.

Authors:  R H Schwartz
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

4.  Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D.

Authors:  L B Pritzker; S Joshi; J J Gowan; G Harauz; M A Moscarello
Journal:  Biochemistry       Date:  2000-05-09       Impact factor: 3.162

Review 5.  The T lymphocyte in experimental allergic encephalomyelitis.

Authors:  S S Zamvil; L Steinman
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

6.  The p41 isoform of invariant chain is a chaperone for cathepsin L.

Authors:  A M Lennon-Duménil; R A Roberts; K Valentijn; C Driessen; H S Overkleeft; A Erickson; P J Peters; E Bikoff; H L Ploegh; P Wolf Bryant
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

7.  Naive T lymphocytes traffic to inflamed central nervous system, but require antigen recognition for activation.

Authors:  M L Krakowski; T Owens
Journal:  Eur J Immunol       Date:  2000-04       Impact factor: 5.532

8.  Primary structure of the gene for the murine Ia antigen-associated invariant chains (Ii). An alternatively spliced exon encodes a cysteine-rich domain highly homologous to a repetitive sequence of thyroglobulin.

Authors:  N Koch; W Lauer; J Habicht; B Dobberstein
Journal:  EMBO J       Date:  1987-06       Impact factor: 11.598

9.  H2-DMalpha(-/-) mice show the importance of major histocompatibility complex-bound peptide in cardiac allograft rejection.

Authors:  N J Felix; W J Brickey; R Griffiths; J Zhang; L Van Kaer; T Coffman; J P Ting
Journal:  J Exp Med       Date:  2000-07-03       Impact factor: 14.307

10.  Multiple discrete encephalitogenic epitopes of the autoantigen myelin basic protein include a determinant for I-E class II-restricted T cells.

Authors:  S S Zamvil; D J Mitchell; M B Powell; K Sakai; J B Rothbard; L Steinman
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

View more
  36 in total

1.  B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity.

Authors:  Martin S Weber; Thomas Prod'homme; Juan C Patarroyo; Nicolas Molnarfi; Tara Karnezis; Klaus Lehmann-Horn; Dimitry M Danilenko; Jeffrey Eastham-Anderson; Anthony J Slavin; Christopher Linington; Claude C A Bernard; Flavius Martin; Scott S Zamvil
Journal:  Ann Neurol       Date:  2010-09       Impact factor: 10.422

2.  Limited sufficiency of antigen presentation by dendritic cells in models of central nervous system autoimmunity.

Authors:  Gregory F Wu; Kenneth S Shindler; Eric J Allenspach; Tom L Stephen; Hannah L Thomas; Robert J Mikesell; Anne H Cross; Terri M Laufer
Journal:  J Autoimmun       Date:  2010-11-20       Impact factor: 7.094

3.  Virus-encoded ectopic CD74 enhances poxvirus vaccine efficacy.

Authors:  Crystal C Walline; Sarah N Deffit; Nan Wang; Lynette M Guindon; Victoria L Crotzer; Jianyun Liu; Kristin Hollister; Laurence C Eisenlohr; Randy R Brutkiewicz; Mark H Kaplan; Janice S Blum
Journal:  Immunology       Date:  2014-04       Impact factor: 7.397

4.  CNS-resident classical DCs play a critical role in CNS autoimmune disease.

Authors:  David A Giles; Patrick C Duncker; Nicole M Wilkinson; Jesse M Washnock-Schmid; Benjamin M Segal
Journal:  J Clin Invest       Date:  2018-10-29       Impact factor: 14.808

5.  Apolipoprotein E mediation of neuro-inflammation in a murine model of multiple sclerosis.

Authors:  Soomin Shin; Katharine A Walz; Angela S Archambault; Julia Sim; Bryan P Bollman; Jessica Koenigsknecht-Talboo; Anne H Cross; David M Holtzman; Gregory F Wu
Journal:  J Neuroimmunol       Date:  2014-03-29       Impact factor: 3.478

6.  B cell antigen presentation is sufficient to drive neuroinflammation in an animal model of multiple sclerosis.

Authors:  Chelsea R Parker Harp; Angela S Archambault; Julia Sim; Stephen T Ferris; Robert J Mikesell; Pandelakis A Koni; Michiko Shimoda; Christopher Linington; John H Russell; Gregory F Wu
Journal:  J Immunol       Date:  2015-04-20       Impact factor: 5.422

7.  Low dose zymosan ameliorates both chronic and relapsing experimental autoimmune encephalomyelitis.

Authors:  Hongmei Li; Patricia Gonnella; Farinaz Safavi; Ghazal Vessal; Bardia Nourbakhsh; Fang Zhou; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  J Neuroimmunol       Date:  2012-09-23       Impact factor: 3.478

8.  Immunodominant T cell determinants of aquaporin-4, the autoantigen associated with neuromyelitis optica.

Authors:  Patricia A Nelson; Mojgan Khodadoust; Thomas Prodhomme; Collin Spencer; Juan Carlos Patarroyo; Michel Varrin-Doyer; Joseph D Ho; Robert M Stroud; Scott S Zamvil
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

9.  Cutting edge: Conditional MHC class II expression reveals a limited role for B cell antigen presentation in primary and secondary CD4 T cell responses.

Authors:  Angela S Archambault; Javier A Carrero; Lisa G Barnett; Nigel G McGee; Julia Sim; Jonathan O Wright; Tobias Raabe; Peiquin Chen; Hua Ding; Eric J Allenspach; Ioannis Dragatsis; Terri M Laufer; Gregory F Wu
Journal:  J Immunol       Date:  2013-06-14       Impact factor: 5.422

10.  The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis.

Authors:  Craig S Clements; Hugh H Reid; Travis Beddoe; Fleur E Tynan; Matthew A Perugini; Terrance G Johns; Claude C A Bernard; Jamie Rossjohn
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.